Prevalence and burden of gait disorders in elderly men and women aged 60-97 years: a population-based study by Mahlknecht, P. et al.
PDF hosted at the Radboud Repository of the Radboud University
Nijmegen
 
 
 
 
The following full text is a publisher's version.
 
 
For additional information about this publication click this link.
http://hdl.handle.net/2066/183583
 
 
 
Please be advised that this information was generated on 2018-04-11 and may be subject to
change.
Prevalence and Burden of Gait Disorders in Elderly Men
and Women Aged 60–97 Years: A Population-Based
Study
Philipp Mahlknecht1, Stefan Kiechl1, Bastiaan R. Bloem2, Johann Willeit1, Christoph Scherfler1,
Arno Gasperi3, Gregorio Rungger3, Werner Poewe1, Klaus Seppi1*
1Department of Neurology, Innsbruck Medical University, Innsbruck, Austria, 2Department of Neurology, Radboud University Nijmegen Medical Center, Nijmegen, The
Netherlands, 3Department of Neurology, Hospital of Bruneck, Bruneck, Italy
Abstract
Background: Although gait disorders are common in the elderly, the prevalence and overall burden of these disorders in
the general community is not well defined.
Methods: In a cross-sectional investigation of the population-based Bruneck Study cohort, 488 community-residing elderly
aged 60–97 years underwent a thorough neurological assessment including a standardized gait evaluation. Gait disorders
were classified according to an accepted scheme and their associations to falls, neuropsychological measures, and quality of
life were explored.
Results: Overall, 32.2% (95% confidence interval [CI] 28.2%–36.4%) of participants presented with impaired gait. Prevalence
increased with age (p,0.001), but 38.3% (95%CI 30.1%–47.3%) of the subjects aged 80 years or older still had a normally
preserved gait. A total of 24.0% (95%CI 20.4%–28.0%) manifested neurological gait disorders, 17.4% (14.3%–21.0%) non-
neurological gait problems, and 9.2% (6.9%–12.1%) a combination of both. While there was no association of neurological
gait disorders with gender, non-neurological gait disorders were more frequent in women (p = 0.012). Within the group of
neurological gait disorders 69.2% (95%CI 60.3%–76.9%) had a single distinct entity and 30.8% (23.1%–39.7%) had multiple
neurological causes for gait impairment. Gait disorders had a significant negative impact on quantitative gait measures, but
only neurological gait disorders were associated with recurrent falls (odds ratio 3.3; 95%CI 1.4–7.5; p = 0.005 for single and
7.1; 2.7–18.7; p,0.001 for multiple neurological gait disorders). Finally, we detected a significant association of gait
disorders, in particular neurological gait disorders, with depressed mood, cognitive dysfunction, and compromised quality
of life.
Conclusions: Gait disorders are common in the general elderly population and are associated with reduced mobility.
Neurological gait disorders in particular are associated with recurrent falls, lower cognitive function, depressed mood, and
diminished quality of life.
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Introduction
Gait disturbances and subsequent falls are among the major
causes of chronic disability in the elderly population and, although
being a common condition, so far have been subject to relatively
few studies assessing overall frequency and clinical characteristics
in community-based samples [1,2]. The lack of data may partially
derive from the absence of standard definitions and criteria for this
heterogeneous group of disorders. Suggestions to classify gait
abnormalities include syndromic approaches based upon the
phenomenological features of gait and associated signs and
symptoms [2–5] as well as etiological approaches asking for the
neurological cause underlying the respective gait abnormality
[3,5–7]. Previous studies mainly used questionnaire-based assess-
ments in the community or did examine gait objectively, but in a
selected hospital-based outpatient cohort with gait disorders [1,6].
Using a syndromic classification only, three studies involving
samples from the Einstein Aging Study cohort found 16% to 20%
of participants aged over 70-years suffering from neurological gait
disorders [2,4,8]. However, these were community-based samples
and not recruited as representative population samples [8].
Therefore, in the general elderly community, the prevalence of
gait disorders still remains to be elucidated. It would also be
helpful to establish the overall gait-related burden due to impaired
mobility, falls, and overall decreased function. To achieve this, we
performed specific investigations in the cohort of the ongoing
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population-based Bruneck Study [9–11].Our aims were to assess
1. the prevalence of neurological and non-neurological gait
disorders according to a well-defined classification system
accounting for sex differences and age trends, 2. the clinical types
of (neurological) gait disorders and their respective severity
assessed by quantitative gait measures, 3. the frequency of falls
and their association to different types of gait disorders, 4. the
association of gait disorders and falls to anxiety, depression, and
cognitive decline, and 5. the impact of gait disorders on quality of
life.
Methods
Participants
Our participants were recruited from the cohort of the Bruneck
Study, a prospective population-based study on the epidemiology
of cardiovascular and neurological diseases [9–11]. Bruneck is a
small town situated in the alpine region of Northern Italy.
Although inhabitants in this area are exclusively Caucasian, their
Austro-German and/or Italian background contributes to hetero-
geneous geographic origins of the study participants. The study
population was recruited as an age- and sex-stratified random
sample of all inhabitants of Bruneck aged 40–79 years. Baseline
assessment took place in 1990 and included 919 of 1000 persons
selected from the official population register, spitted into age
groups according to decades (125 women and 125 men in every
decade from 40 to 79 years). Follow-up assessments were
scheduled every five years. From the surviving 576 subjects, 488
returned for the last follow-up assessment in 2010 (follow-up rate
84.7%) and were used for the present cross-sectional study. Out of
a total of 14 institutionalized subjects from the Bruneck Study
cohort at that point in time, 11 were seen during the Bruneck
Study 2010 and included in the present analysis. For the purpose
of comparing age related differences, we divided our population in
three subgroups of 60–69 (n = 205), 70–79 (n = 163), and 80–97
(n = 120) years of age.
Ethics
The study protocol was approved by the local ethics committee
(institutional review board of the local medical service of south
Tyrol, Bolzano, Italy) and all participants gave written informed
consent. All investigations were carried out in accordance to the
principles expressed in the Declaration of Helsinki.
Procedures
The study protocol included a clinical neurological assessment
with emphasis on movement disorders. The interviews and
examinations were carried out by two neurologists (one senior
neurologist with special expertise in movement disorders and one
fellow in the field of movement disorders). Firstly, a careful general
history, including family- and past medical history, was taken and
screening for secondary causes of disease, especially movement
disorders including drug-exposure was performed. Standard
interviews sought for clinical symptoms suggestive of gait disorders
such as slowness of movements, difficulties of gait (insecurity,
scuffing shoes, short steps, and getting glued feet to the floor)
feeling of unsteadiness and imbalance, fear of falling, and the
frequency of falls over the past year. Falls, also ascertained from
history, were defined as a subject unintentionally coming down on
the floor not due to a major intrinsic or extrinsic event [12].
Recurrent falls were defined as more than one fall within the last
year. Cognitive performance was measured by the Mini Mental
State Examination (MMSE). Mood was evaluated by the Beck
Depression Inventory (BDI) and the Hospital Anxiety and
Depression Scale (HADS-Anxiety and HADS-Depression). Qual-
ity of life (QoL) was assessed using the multidimensional World
Health Organization QoL BREF (WHOQoL-BREF) instrument.
Subsequently, all participants underwent a standardized neu-
rological examination including the UPDRS-III (Unified Parkin-
son’s Disease Rating Scale, motor section). Classification of
participants with clinical signs of parkinsonism was done according
to current diagnostic criteria for parkinsonian disorders [13]. Due
to a lack of standard definition or criteria for the rather
heterogeneous group of gait disorders, we decided to resort to a
well-defined classification system recently published by Snijders
and colleagues [3]. It consists of a practical approach based on a
three step model. Step one leads to a possible, clinically based gait
disorder. Within this first step, three elements were captured: (1)
core gait features were assessed while observing participants
walking for 10 meters, turning, and walking back seeking for e.g.
high steppage with dropping foot, (bilateral) circumduction,
staggering and wide-based gait, shuffling gait, hesitation and
freezing, ‘walking on ice’, etc.; (2) additional clinically based gait
and balance tests regularly included the Unterberger-, the
Romberg’s-, and the pull test, the tandem-walk and walking while
keeping eyes closed to test for balance and postural stability, the
heel- and toe walk to test for strength and the stop walking while
talking tool to test for aggravation upon performance of a
secondary task; (3) associated symptoms and signs were assessed
during the general neurological evaluation seeking for e.g. lower
motor neuron features, disturbed proprioception, cerebellar
ataxia, parkinsonism, frontal release signs, etc. Step two includes
ancillary investigations, response to treatment, and prolonged
follow-up and leads to a probable diagnosis. As this study was
performed in the Bruneck hospital, information about potential
reasons for gait impairment was available (e.g. brain imaging,
glucose, and HbA1c levels, vitamin B12 deficiency, response to
dopaminergic treatment, longitudinal clinical data, etc.) and a
probable etiological diagnosis of gait impairment could be made.
The classification included nine neurological gait disorders: I
paretic/hypotonic, II spastic, III sensory ataxic, IV cerebellar
ataxic, V vestibular ataxic, VI dyskinetic, VII hypokinetic-rigid
(parkinsonian), VIII cautious, and IX higher-level [3]. Gait
disorders resulting from more than one neurological condition
were classified and reported as ‘multiple’ and the contributing
elements were noted. Step three consists of a post-mortem
examination leading to a definite diagnosis and was not
performed. Apart from these neurological causes, we subsumed
orthopaedic, including an antalgic gait (due to e.g. joint pain), and
ophthalmologic reasons for gait impairment as non-neurological
causes. Gait disorders resulting from both neurological and non-
neurological causes were classified and reported as ‘combined’.
Impairment was defined as mild (no assistance required), moderate
(dependent on walking aid) or severe (non-ambulant) [2]. As
quantitative gait measures, the Hauser ambulation index [14], the
Tinetti balance and gait scale [15], and the Timed Up and Go test
[16] were applied. Overall gait speed was measured during
undisturbed straight walking at the subject’s own comfortable
speed over a distance of 8 meters using a simple stop watch.
Inter-rater Reliability
To assess the reliability of gait evaluations, an independent
sample of 43 inpatients at the department of neurology from the
Innsbruck Medical University with distinct neurological diagnoses
were examined by the two study clinicians blinded to the results of
each other. There was high agreement between the two
assessments in the classification of the various gait disorders
(kappa ranging from 0.78 to 0.99, each p,.001). Overall
Prevalence and Burden of Gait Disorders
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unweighted kappa was 0.95 (p,0.001). Therefore a good inter-
rater reliability was achieved.
Statistical Analysis
Data were tabulated and analyzed using SPSS 20.0 for windows
(SPSS Inc., Chicago, IL). Prevalence rates are given in percent of
the respective category. Ninety-five percent confidence intervals
(95%CI) were calculated using the modified Wald method [17].
The chi-square test was used for gender and age category
distribution. As data from the qquantitative gait measures (Hauser
index, Tinetti scale, Timed Up and Go test and gait speed) were
not normally distributed, group comparisons for these severity
measures were performed with Mann-Whitney-U tests and post-
hoc Bonferroni corrections. Impact of various gait disorders and
the quantitative gait measures on the occurrence of recurrent falls
as well as associations of age, gender, cognition, and mood on the
occurrence of gait disorders, neurological gait disorders, and
recurrent falls were assessed with an unconditional logistic
regression analysis. Associations were expressed by the odds ratio
(OR). For continuous variables (age, Hauser index, Tinetti scale,
Timed Up and Go test, gait speed, MMSE, BDI, HADS-Anxiety,
and HADS-Depression) ORs were calculated for a one standard
deviation unit change in variable levels in order to render the odds
comparable. The significance level was set at p,0.05.
Results
Prevalence of Gait Disorders
Of the 488 participants, 142 reported difficulties while walking
(29.1%; 95%CI 25.2%–33.3%), but 18 of them (3.7%; 2.3%–
5.8%) showed no gait abnormalities during the neurological
examination at the time of the visit. Overall, 157 participants
(32.2%; 95%CI 28.2%–36.4%) had a gait disorder upon
examination, 33 of these subjects were not aware of it (6.8%;
4.8%–9.4%). The frequency of gait disorders was strongly age-
related (p,0.001; Table 1). Gait disorders tended to be more
prevalent in women than in men (p= 0.053) and women more
frequently reported difficulties while walking (p,0.001).
Types and Severity of Gait Disorders
As outlined in Table 1, 117 subjects showed a neurological gait
disorder and 85 a non-neurological gait disorder. Of these, 45
subjects had combined reasons for their gait impairment. A
detailed breakdown of neurological gait disorders is represented in
Table 2; 81 subjects suffered from a distinct entity and 36 from
multiple neurological gait disorders. In the latter group single
combinations were close to the proportions expected by chance,
except for the combination of higher-level and sensory ataxic gait.
There was no association of neurological gait disorders with
gender. Within this group, however, the cautious walking pattern
was associated to female gender (p = 0.017). Also, non-neurolog-
ical gait disorders were associated with female gender (p = 0.012).
Non-neurological gait disorders occurred due to osteoarthritis of
the knee (n = 28), and the hip (n = 23) and various other
orthopaedic reasons in the remaining subjects as well as
ophthalmological reasons leading to visual disturbances in 12
cases. All 11 institutionalized subjects had a neurological gait
disorder, 7 in combination with a non-neurological gait disorder.
Quantitative gait measures for the different gait disorders are
shown in Table 3. All used measures significantly display gait
impairment in all neurological gait disorders compared to healthy
subjects (p,0.001), except for the Timed Up and Go test and gait
speed in vestibular and cerebellar ataxic gait, where all subjects
had a mild severity of the gait disorder. Greatest impairment was
found in spastic and higher-level gait, and in multiple neurological
gait disorders, where over one third were moderately to severely
affected. Also pure non-neurological gait disorders lead to
significant gait impairment, which was even higher when
combined with a neurological gait disorder (p,0.001).
Falls
Overall, 45 subjects (9.2%; 95%CI 6.9%–12.1%) suffered from
recurrent falls over the past year (32 women and 13 men;
p = 0.018) and all of them had a gait disorder. Thus, of the subjects
with gait disorders 28.7% (95%CI 22.2%–36.2%) fell recurrently
and 20.4% (14.8%–27.4%) reported fear of falling (29 women and
3 men; p,0.001), including the 7 subjects with a cautious gait.
Mean frequency of falls was 0.8 per month, ranging from twice a
year to once a day. Table 4 presents the associations of various
Table 1. Prevalence of gait disorders, according to sex and age.
Sex Age category Total No. GD No., % (95%CI) Neurological No. Combined No. Non-neurological No.
Mena 60–69 103 12 11.7 (6.7–19.4) 6 3 3
70–79 79 27 34.2 (24.7–45.2) 14 4 9
80–97 45 24 53.3 (39.1–67.1) 14 7 3
Total 227 63 27.8 (22.3–33.9) 34 14 15
Womena 60–69 102 10 9.8 (5.2–17.3) 2 2 6
70–79 84 34 40.5 (30.6–51.2) 10 10 14
80–97 75 50 66.7 (55.4–76.3) 26 19 5
Total 261 94 36.0 (30.4–42.0) 38 31 25
Men and Women 60–69b 205 22 10.7 (7.1–15.8) 8 5 9
70–79b 163 61 37.4 (30.4–45.1) 24 14 23
80–97b 120 74 61.7 (52.7–69.9) 40 26 8
Total 488 157 32.2 (28.2–36.4) 72 45 40
Abbreviations: GD, gait disorders.
aSignificance for sex difference: p = 0.053;
bsignificance for age trends: p,0.001.
doi:10.1371/journal.pone.0069627.t001
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types of gait disorders with recurrent falls; neurological gait
disorders, but not non-neurological gait disorders were signifi-
cantly associated to recurrent falls. Also quantitative gait measures
were significantly associated with falls, particularly reduced gait
speed.
Neuropsychological Associations of Gait Disorders and
Falls
A logistic regression analysis revealed that age, lower mental
function and depression (but not anxiety) were significantly
associated with gait disorders, in particular neurological gait
disorders and recurrent falls (Table 5). Correction for age and
gender did not alter these results.
Quality of Life
WHOQoL-BREF scores are diminished in subjects with gait
disorders, in particular neurological gait disorders, for general
QoL and quality of health as well as in the domains physical
health, psychological health and environment, but not in the
domain social relationships (Table 6).
Discussion
In this unselected population-based cohort representing the
general elderly community, we detected a high overall prevalence
of gait disorders, affecting one third of our subjects with a marked
age-dependent increase. Gait was carefully and comprehensively
evaluated according to an established [3] and further standardized
protocol, with a combination of detailed history taking, detailed
gait assessment including core gait features plus a standard set of
gait and balance tests, general neurological examination, and the
results of ancillary studies. Consequently, gait disorders were
classified syndromically and etiologically according to an accepted
scheme [3], separating clearly defined neurological gait disorders
from non-neurological gaits, or combinations thereof. In the
Bruneck Study cohort, 24.0% of participants had a neurological
gait problem, 17.4% suffered from non-neurological gait disorders,
and 9.2% had combinations of both. Within the subgroup of
neurological gait disorders, 69.2% suffered from distinct neuro-
logical entities and 30.8% had multiple neurological causes. The
sensory ataxic, higher-level and parkinsonian gait were the most
common subtypes. The high prevalence of sensory ataxic gait
represents an understandable finding, considering the fact that
peripheral sensory neuropathy is common in the elderly and may
easily affect gait function [6,18]. White matter lesions can underlie
higher-level gait disorders and these white matter lesions are
associated with vascular risk factors such as advanced age,
diabetes, and obesity [3,19,20]. The same factors can also
contribute to a sensory gait ataxia [18], explaining the frequent
coexistence of these two conditions in our sample. The high
frequency of parkinsonian gait features in the elderly has already
been described [6,21]. However, our detailed diagnostic approach
Table 2. Prevalence of the various neurological gait disorders.
Neurological GD No.(#)
% of neurological
GD (95%CI)
Total
No. (1) Causes (No.)
Single neurological 81 69.2 (60.3–76.9)
Sensory ataxic 22 18.0 (12.7–26.9) 46 Peripheral sensory neuropathy (46)b
Parkinsonian 19 16.2 (10.6–24.1) 34 18 definite Parkinson’s disease (18), drug-induced parkinsonism (8),
dementia with parkinsonism (4), parkinsonism (4)c
Higher level 9 7.7 (3.9–14.2) 31 CT-scan confirmed vascular encephalopathy (20) and normal
pressure hydrocephalus (1), severe dementia (7), hypoxic ischemic
encephalopathy (1), clinical gait apraxia of unknown reason (2)
Cerebellar ataxic 7 6.0 (2.7–12.0) 10 Cerbellar stroke (3), cerebellar lesion due to multiple sclerosis (1),
severe essential termor (3), post-vaccinal cerebellitis (1), chronic
alcohol abuse (1), multiple system atrophy (1)
Cautious 7 6.0 (2.7–12.0) 7 Idiopathic, associated to fear of falling (7)d
Paretic/hypotonic 6 5.1 (2.1–11.0) 14 Neurogenic claudication (7), diabetes type 2 neuropathy (1), nerve
leasion due to trauma (3) or surgery (1), distal paraparesis as residual
after Guillain–Barre´ syndrome (1), unknown (2)
Spastic 6 5.1 (2.1–11.0) 7 Ischemic stroke (3), intracerebral hemorrhage (3), congenital (1)
Vestibular ataxic 4 3.4 (1.1–8.8) 6 Bilateral vestibulopathy (3), recent vestibular neuronitis (1),
recent Meniere’s attack (1); acoustic neuroma with surgery (1)
Dyskinetic 1 0.9 (0.0–5.2) 4 levodopa-induced dyskinesia (3), chorea (1)
Multiple Neurological GDa 36 30.8 (23.1–39.7)
Total 117
The table lists No (#) and Total No (1). No (#) stands for gait disorders, which were single entities in 81 subjects and multiple gait disorders due to combinations of
different entities in 36 subjects. Total No (1) stands for the total number of subjects presenting with a specific gait disorder. For the subjects with multiple gait disorders
their contributors are listed additionally in the legend (see a). E.g. there are 22 subjects who presented with sensory ataxia as a single neurological gait disorder [i.e. No
(#)] and another 24 subject with a sensory ataxic gait in combination with other neurological gait disorders adding up to a total of 46 subjects with this gait
abnormality [i.e. Total No (1)].Abbreviations: GD, gait disorders.
aContributors to multiple neurological GD (No.): Sensory ataxic (24), higher level (22), parkinsonian (15), paretic/hypotonic (8), cerebellar ataxic (3), vestibular ataxic (2),
dyskinetic (3), spastic (1);
bDiagnosed in the presence of neuropathic symptoms (numbness, altered sensation, or pain in the feet) and neurologic signs (decreased ankle reflexes, decreased distal
sensation, and disturbed vibration sense) according to current criteria [30];
cSubjects with a parkinsonian syndrome not fulfilling criteria for definite Parkinson’s disease [13];
dWith core gait features of a slow, wide base gait with short steps like ‘walking on ice’ [3].
doi:10.1371/journal.pone.0069627.t002
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additionally revealed that such gait emerged mostly due to PD, but
also due to secondary parkinsonism. Severity measures displayed
the greatest functional impairment in spastic and higher level gait,
as well as in multiple neurological gait disorders. Subjects with
cerebellar ataxic and vestibular gait were less impaired. These
participants were younger and all of them were mildly affected.
The overall trend of a higher prevalence of gait disorders in
women could be explained by a significant higher prevalence of
non-neurological gait disorders in women. A plausible contributor
to this female preponderance may be the higher prevalence of
joint-pain in women as reported in literature [2,22]. Among the
neurological gait disorders only the cautious walking pattern was
significantly associated to female gender. This is in line with our
and previous findings in the community showing a higher
prevalence of fear of falling in women [23].
Recurrent falls occurred in one tenth of our cohort, whereas
community-based studies found that one sixth of the population
aged 65 years or older experience recurrent falls [24]. The
relatively lower fall rate may be explained by the lower age of our
subjects, but might, however, also represent an underestimation as
we relied upon a single interview to determine fall-frequency.
Nevertheless, fall-related results seem to be accurate as female
gender and slow gait were significantly associated to the risk of falls
as previously reported [8,25]. Interestingly, all fallers had a gait
disorders and subjects with a neurological gait disorders were three
times more likely to suffer from recurrent falls. Among neurolog-
ical gait disorders the parkinsonian, sensory ataxic, spastic, higher
level gait, and particularly multiple neurological gait disorders
were significantly associated with recurrent falls. The same
occurred for reduced gait performance as measured with the
objective gait tests, particularly reduced gait speed. Therefore,
timely gait assessment is likely to identify subjects at increased risk
of falling. Gait is a marker for otherwise undetected and perhaps
treatable disease and falls could be prevented or postponed in
Table 3. Gait disorders and association to gait measures.
Gait disorders (No.) Hauser index [0–8] Tinetti score [0–28] Timed up and go [sec] Gait speed [cm/sec] Severity (%)a
One neurological (81) 2.4 (1.7) 21.0 (5.8) 14.6 (6.5) 87.0 (25.6) 16
Sensory ataxic (22) 2.3 (1.8) 21.5 (6.0) 13.5 (6.0) 88.7 (24.6) 18
Parkinsonian (19) 2.1 (1.6) 22.1 (1.7) 15.6 (3.7) 88.6 (21.1) 16
Higher Level (9) 3.4 (2.5) 17.1 (8.7) 19.3 (8.1) 81.1 (31.0) 33
Cerebellar ataxic (7) 2.0 (0.6) 22.3 (2.8) 10.4 (2.2) 100.6 (35.9) 0
Cautious (7) 2.3 (1.1) 21.6 (4.0) 13.9 (3.2) 80.0 (22.0) 14
Paretic/hypotonic (6) 2.3 (1.4) 20.1 (4.8) 16.4 (9.3) 86.9 (31.8) 17
Spastic (6) 2.8 (1.8) 17.3 (5.8) 23.7 (12.8) 69.8 (28.5) 33
Vestibular ataxic (4) 1.8 (1.0) 22.8 (1.7) 10.6 (0.6) 91.3 (18.4) 0
Dyskinetic (1) 0
Multiple Neurological (36) 3.7 (2.4) 15.9 (7.6) 17.2 (7.4) 71.8 (30.9) 44
Total neurological (117) 2.8 (2.0) 19.4 (6.8) 15.5 (6.9) 82.7 (28.0) 25
Only neurological GD (72) 2.4 (1.8) 21.0 (5.8) 13.8 (4.9) 86.0 (26.6) 15
Only non-neurological GD (40) 1.9 (1.2) 23.7 (3.9) 12.8 (4.5) 93.4 (23.9) 15
Combined (45) 3.4 (2.2) 16.9 (7.6) 18.5 (8.7) 77.1 (29.6) 40
Total GD 2.6 (1.9) 20.5 (6.4) 14.8 (6.4) 85.4 (27.3) 22
No GD (331) 0.1 (0.3) 28.0 (0.2) 8.9 (1.6) 122.3 (22.2) –
Abbreviations: GD, gait disorders.
Results of the Hauser index, Tinetti score, Timed up and go test and gait speed are reported in means (SD, standard deviation).
aProportion of subjects with a moderate (dependent on walking aid) or severe (non-ambulant) gait disorder.
doi:10.1371/journal.pone.0069627.t003
Table 4. Odds ratios of recurrent falls for the various types of
gait disorders and gait speed.
Variable
Fallers
No.
Total
No. OR (95%CI) P-value
Sensory ataxic 18 46 3.7 (1.5–9.3) 0.006
Parkinsonian 15 34 5.3 (2.0–14.2) 0.001
Higher level 16 31 3.2 (1.1–9.4) 0.030
Cerebellar ataxic 4 10 3.0 (0.4–21.0) 0.262
Cautiousa 1 7 – –
Paretic/hypotonic 5 14 2.9 (0.7–11.6) 0.124
Spastic 4 7 20.9 (2.2–202.4) 0.009
Vestibulara 1 6 – –
Dyskinetica 1 4 – –
One neurological GD 21 81 2.4 (1.0–5.4) 0.039
Multiple neurological GD 20 36 7.1 (2.7–18.7) ,0.001
Only neurological GD 22 72 3.3 (1.4–7.5) 0.005
Only non neurological GD 4 40 1.4 (0.4–5.1) 0.655
Combined GD 19 45 4.1 (1.6–10.2) 0.003
Hauser indexb 4.7 (2.8–7.7) ,0.001
Tinett scoreb 3.9 (2.5–6.1) ,0.001
Timed Up and Go testb 2.7 (1.6–4.3) ,0.001
Gait speedb 5.5 (2.8–11.0) ,0.001
Abbreviations: GD, Gait disorders; OR, odds ratios.
OR are calculated by logistic regression analysis and corrected for age, gender
and MMSE-scores.
aNumbers too low in the respective category for the calculation of the ORs.
bFor continuous variables ORs were calculated for a one standard deviation unit
change in variable levels in order to render odds comparable.
doi:10.1371/journal.pone.0069627.t004
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these subjects using a tailored treatment approach. Furthermore,
among the subjects aged over 80 years, 38.3% still had a normally
preserved gait, underlining that gait impairment must not be
accepted as an inevitable concomitant of aging.
Although we have not applied an extensive neuropsychological
testing battery, we could detect a significant association of lower
cognitive function and higher depression scores with gait disorders
and falls. Deficits in executive functions are known to influence
gait [26,27,28] and may represent prodrome to falls [29].
Therefore, the lower MMSE-scores in our subjects with gait
disorder may display a cognitive impairment and indicate a higher
risk for falls.
Another important novel finding of this study is that QoL
scores, as assessed by the generic measure WHOQOL-BREF, are
significantly impaired in subjects with gait disorders. The worst
affected areas compared to subjects without gait disorders were
those related to physical and psychological health and to a lesser
extent environmental functioning, whereas social relationship was
not impaired. Future studies should assess predictors and
correlates of QoL in subjects with gait disorders.
Our assessment has several strengths including the relatively
large cohort of the Bruneck Study, representing a typical elderly
western population with respect to demographic and lifestyle
characteristics. Gait was carefully and comprehensively evaluated
according to an established [3] and further standardized protocol,
allowing for an accurate syndromic and etiological categorisation
of gait disturbances according to an accepted scheme [3]. Inter-
rater reliability of this classification system was high. There are,
however, limitations to this study. The population size of 488 leads
to rather wide confidence intervals and does not allow a precise
estimate of rare diseases’ prevalence. Although participation rate
was high with nearly 85%, we cannot exclude significant
differences between participating subjects and those who did not
with regard to presence of gait disorders and falls. Nevertheless,
due to the population-based nature of the Bruneck Study, the
relative contributions of the various types of gait disorders are
likely to be an accurate reflection of real life. Prevalence rates
obtained here, however, do not necessarily apply to other ethnic
groups and might vary in different populations. Also, our study
lacks an evaluation of gait features with the help of videotaping or
kinematic assistances. However, the merits of such techniques, in
particular the objective kinematic measures, compared to gait-
assessment by an experienced clinician remain to be established.
Finally, the cross-sectional nature of the present study did not
allow for a prospective assessment of the gait-related burden.
Further follow-ups of this well described cohort will give additional
information on the association of gait disorders with potential
serious complications such falls and fractures as well as nursing
home placement and mortality.
To our knowledge, there is no previous study reporting the
prevalence, distribution and clinical characterisation of gait
disorders and their functional correlates in a cohort representative
for the general community. Our study suggests that gait disorders
are common in the general elderly population and are associated
with reduced mobility. Neurological gait disorders in particular are
associated with recurrent falls, lower cognitive function, depressed
Table 5. Association of age, gender, cognition and mood
with gait disorders, neurological gait disorders and recurrent
falls.
Variable Unadjusted
Adjusted for age and
gender
OR (95%CI) P-value OR (95%CI) P-value
Gait disorders (n=157)
Age 3.4 (2.7–4.4) ,0.001 – –
Gender (w:m) 1.5 (1.0–2.2) 0.052 – –
MMSE (decline) 3.0 (2.2–4.1) ,0.001 1.8 (1.3–2.5) ,0.001
BDI 1.7 (1.3–2.3) ,0.001 1.6 (1.2–2.2) 0.002
HADS-Anxiety 1.1 (0.9–1.4) 0.266 1.1 (0.9–1.4) 0.477
HADS-Depression 1.7 (1.4–2.1) ,0.001 1.5 (1.2–1.9) 0.001
Neurological gait disorders (n=117)
Age 3.9 (2.9–5.1) ,0.001 – –
Gender (w:m) 1.3 (0.9–2.0) 0.173 – –
MMSE (decline) 3.6 (2.6–4.9) ,0.001 2.0 (1.5–2.9) ,0.001
BDI 1.8 (1.4–2.4) ,0.001 1.8 (1.3–2.4) 0.001
HADS-Anxiety 1.1 (0.9–1.4) 0.229 1.1 (0.9–1.4) 0.349
HADS-Depression 1.8 (1.4–2.2) ,0.001 1.5 (1.2–2.0) 0.001
Recurrent falls (n = 45)
Age 4.5 (3.0–6.9) ,0.001 – –
Gender (w:m) 2.3 (1.2–4.4) 0.018 – –
MMSE (decline) 2.2 (1.6–3.0) ,0.001 1.5 (1.1–2.0) 0.019
BDI 1.9 (1.3–2.7) 0.001 1.8 (2.0–2.7) 0.005
HADS-Anxiety 1.1 (0.8–1.6) 0.410 1.0 (0.7–1.5) 0.901
HADS-Depression 1.9 (1.5–2.5) ,0.001 1.5 (1.1–2.1) 0.011
Abbreviations: MMSE, Mini Mental State Examination; BDI, Beck Depression
Inventory; HADS, Hospital Anxiety and Depression Scale; OR, odds ratio.
ORs are calculated by logistic regression analysis. For continuous variables (age,
MMSE, BDI, and HADS) ORs were calculated for a one standard deviation unit
change in variable levels in order to render odds comparable.
doi:10.1371/journal.pone.0069627.t005
Table 6. Association of gait disorders and neurological gait disorders with quality of life.
General Physical health Psychological health Social relationships Environment
All GD 68.4 (615.0)
p,0.001
76.4 (611.9)
p,0.001
72.4 (614.0)
p = 0.005
71.6 (612.6)
ns
82.3 (69.9)
p = 0.038
Neurological GD 67.0 (615.0)
p,0.001
75.2 (612.3)
p,0.001
70.6 (614.3)
p = 0.001
70.3 (611.4)
ns
81.3 (69.9)
p = 0.009
No GD 76.6 (612.3) 84.7 (68.7) 77.9 (611.5) 73.1 (612.2) 84.9 (69.5)
Abbreviations: GD, Gait disorders.
The self administered WHO Quality of Life-BREF questionnaire assesses the general quality of life and health as well as the QoL in the four domains physical health,
psychological health, social relationships, and environment. Results are reported in mean transformed scores (where 100 points represent maximum of respective item,
6 standard deviation); P values refer to differences to the group without GD and are corrected for age and gender.
doi:10.1371/journal.pone.0069627.t006
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mood, and diminished QoL. The results of our study should
increase awareness among clinicians and health authorities to the
high prevalence and associated disease burden of gait disorders, in
particular neurological gait disorders, in the general elderly
community.
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